BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38354523)

  • 1. Novel inhibitors targeting the PGK1 metabolic enzyme in glycolysis exhibit effective antitumor activity against kidney renal clear cell carcinoma in vitro and in vivo.
    He Y; Luo Y; Huang L; Zhang D; Hou H; Liang Y; Deng S; Zhang P; Liang S
    Eur J Med Chem; 2024 Mar; 267():116209. PubMed ID: 38354523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis.
    He Y; Wang X; Lu W; Zhang D; Huang L; Luo Y; Xiong L; Li H; Zhang P; Li Q; Liang S
    Cell Death Dis; 2022 Feb; 13(2):118. PubMed ID: 35121728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel inhibitor of PGK1 suppresses the aerobic glycolysis and proliferation of hepatocellular carcinoma.
    Li M; Zhang A; Qi X; Yu R; Li J
    Biomed Pharmacother; 2023 Feb; 158():114115. PubMed ID: 36516697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis.
    Li X; Jiang Y; Meisenhelder J; Yang W; Hawke DH; Zheng Y; Xia Y; Aldape K; He J; Hunter T; Wang L; Lu Z
    Mol Cell; 2016 Mar; 61(5):705-719. PubMed ID: 26942675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis.
    Zhang Y; Yu G; Chu H; Wang X; Xiong L; Cai G; Liu R; Gao H; Tao B; Li W; Li G; Liang J; Yang W
    Mol Cell; 2018 Jul; 71(2):201-215.e7. PubMed ID: 30029001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth.
    Nie H; Ju H; Fan J; Shi X; Cheng Y; Cang X; Zheng Z; Duan X; Yi W
    Nat Commun; 2020 Jan; 11(1):36. PubMed ID: 31911580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52.
    Wang WL; Jiang ZR; Hu C; Chen C; Hu ZQ; Wang AL; Wang L; Liu J; Wang WC; Liu QS
    Acta Pharmacol Sin; 2021 Apr; 42(4):633-640. PubMed ID: 32737469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of PGK1 under hypoxic conditions promotes glycolysis and increases stem cell‑like properties and the epithelial‑mesenchymal transition in oral squamous cell carcinoma cells via the AKT signalling pathway.
    Zhang Y; Cai H; Liao Y; Zhu Y; Wang F; Hou J
    Int J Oncol; 2020 Sep; 57(3):743-755. PubMed ID: 32705252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN Suppresses Glycolysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1.
    Qian X; Li X; Shi Z; Xia Y; Cai Q; Xu D; Tan L; Du L; Zheng Y; Zhao D; Zhang C; Lorenzi PL; You Y; Jiang BH; Jiang T; Li H; Lu Z
    Mol Cell; 2019 Nov; 76(3):516-527.e7. PubMed ID: 31492635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis.
    Liu H; Chen X; Wang P; Chen M; Deng C; Qian X; Bai J; Li Z; Yu X
    Cell Death Dis; 2024 Feb; 15(2):170. PubMed ID: 38402202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PGK1 : An Essential Player in Modulating Tumor Metabolism.
    Duncan L; Shay C; Teng Y
    Methods Mol Biol; 2022; 2343():57-70. PubMed ID: 34473315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles and mechanisms of phosphoglycerate kinase 1 in cancer.
    Chen Y; Cen L; Guo R; Huang S; Chen D
    Bull Cancer; 2022 Dec; 109(12):1298-1307. PubMed ID: 36096942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The basic functions of phosphoglycerate kinase 1 and its roles in cancer and other diseases.
    Liu H; Wang X; Shen P; Ni Y; Han X
    Eur J Pharmacol; 2022 Apr; 920():174835. PubMed ID: 35183535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma.
    Lin J; Liu Y; Liu P; Qi W; Liu J; He X; Liu Q; Liu Z; Yin J; Lin J; Bao H; Lin J
    J Exp Clin Cancer Res; 2023 Dec; 42(1):339. PubMed ID: 38098044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PGK1 is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1α-Mediated Epithelial-Mesenchymal Transition Process in Breast Cancer.
    Fu D; He C; Wei J; Zhang Z; Luo Y; Tan H; Ren C
    Cell Physiol Biochem; 2018; 51(5):2434-2444. PubMed ID: 30537744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGK1 Drives Hepatocellular Carcinoma Metastasis by Enhancing Metabolic Process.
    Xie H; Tong G; Zhang Y; Liang S; Tang K; Yang Q
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28749413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase activity of the glycolytic enzyme PGK1 regulates autophagy to promote tumorigenesis.
    Qian X; Li X; Lu Z
    Autophagy; 2017 Jul; 13(7):1246-1247. PubMed ID: 28486006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis.
    Hu H; Zhu W; Qin J; Chen M; Gong L; Li L; Liu X; Tao Y; Yin H; Zhou H; Zhou L; Ye D; Ye Q; Gao D
    Hepatology; 2017 Feb; 65(2):515-528. PubMed ID: 27774669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphoglycerate kinase 1 (PGK1) in cancer: A promising target for diagnosis and therapy.
    Fu Q; Yu Z
    Life Sci; 2020 Sep; 256():117863. PubMed ID: 32479953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncogenic role and regulatory mechanism of PGK1 in human non-small cell lung cancer.
    Tian T; Leng Y; Tang B; Dong X; Ren Q; Liang J; Liu T; Liu Y; Feng W; Liu S; Zhou Y; Zhao H; Shen L
    Biol Direct; 2024 Jan; 19(1):1. PubMed ID: 38163864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.